University of Pennsylvania

ScholarlyCommons
Departmental Papers (Dental)

Penn Dental Medicine

11-2006

Actinobacillus Actinomycetemcomitans Leukotoxin Requires
Lipid Microdomains for Target Cell Cytotoxicity
Karen P. Fong
Cinthia M.F. Pacheco
Linda T. Otis
Samesh Baranwal
Irene R. Keiba

See next page for additional authors

Follow this and additional works at: https://repository.upenn.edu/dental_papers
Part of the Dentistry Commons

Recommended Citation
Fong, K. P., Pacheco, C. M., Otis, L. T., Baranwal, S., Keiba, I. R., Harrison, G., Hersh, E. V., Boesze-Battaglia,
K., & Lally, E. T. (2006). Actinobacillus Actinomycetemcomitans Leukotoxin Requires Lipid Microdomains
for Target Cell Cytotoxicity. Cell Microbiology, 8 (11), 1753-1767. http://dx.doi.org/10.1111/
j.1462-5822.2006.00746.x

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/dental_papers/210
For more information, please contact repository@pobox.upenn.edu.

Actinobacillus Actinomycetemcomitans Leukotoxin Requires Lipid Microdomains
for Target Cell Cytotoxicity
Abstract
Actinobacillus actinomycetemcomitans produces a leukotoxin (Ltx) that kills leukocyte functionassociated antigen-1 (LFA-1)-bearing cells from man, the Great Apes and Old World monkeys. The unique
specificity of Ltx for the β2 integrin, LFA-1, suggests it is capable of providing insight into the pathogenic
mechanisms of Ltx and other RTX toxins. Using the Jurkat T cell line and an LFA-1-deficient Jurkat mutant
(Jβ2.7) as models, we found the initial effect of Ltx is to elevate cytosolic Ca2+ [Ca2+]c, an event that is
independent of the Ltx/LFA-1 interaction. [Ca2+]c increases initiate a series of events that involve the
activation of calpain, talin cleavage, mobilization to, and subsequent clustering of, LFA-1 in cholesterol
and sphingolipid-rich regions of the plasma membrane known as lipid rafts. The association of Ltx and
LFA-1 within lipid rafts is essential for cell lysis. Jβ2.7 cells fail to accumulate Ltx in their raft fractions
and are not killed, while cholesterol depletion experiments demonstrate the necessity of raft integrity for
Ltx function. We propose that toxin-induced Ca2+ fluxes mobilize LFA-1 to lipid rafts where it associates
with Ltx. These findings suggest that Ltx utilizes the raft to stimulate an integrin signalling pathway that
leads to apoptosis of target cells.
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Actinobacillus actinomycetemcomitans leukotoxin requires lipid
microdomains for target cell cytotoxicity
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Gerald Harrison, Elliot V. Hersh, Kathleen Boesze-Battaglia, and Edward T. Lally*
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Summary
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Actinobacillus actinomycetemcomitans produces a leukotoxin (Ltx) that kills leukocyte functionassociated antigen-1 (LFA-1)-bearing cells from man, the Great Apes and Old World monkeys.
The unique specificity of Ltx for the β2 integrin, LFA-1, suggests it is capable of providing insight
into the pathogenic mechanisms of Ltx and other RTX toxins. Using the Jurkat T cell line and an
LFA-1-deficient Jurkat mutant (Jβ2.7) as models, we found the initial effect of Ltx is to elevate
cytosolic Ca2+ [Ca2+]c, an event that is independent of the Ltx/LFA-1 interaction. [Ca2+]c
increases initiate a series of events that involve the activation of calpain, talin cleavage,
mobilization to, and subsequent clustering of, LFA-1 in cholesterol and sphingolipid-rich regions
of the plasma membrane known as lipid rafts. The association of Ltx and LFA-1 within lipid rafts
is essential for cell lysis. Jβ2.7 cells fail to accumulate Ltx in their raft fractions and are not killed,
while cholesterol depletion experiments demonstrate the necessity of raft integrity for Ltx
function. We propose that toxin-induced Ca2+ fluxes mobilize LFA-1 to lipid rafts where it
associates with Ltx. These findings suggest that Ltx utilizes the raft to stimulate an integrin
signalling pathway that leads to apoptosis of target cells.

Introduction
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Actinobacillus actinomycetemcomitans produces a 116 kDa leukotoxin (Ltx) that is a
member of the RTX (Repeats in ToXin) family (Welch, 1991) of cytolytic proteins and has
a unique specificity for human immune cells (Taichman et al., 1987). A paradigm observed
with many bacterial protein toxins is that target cell recognition (Parker et al., 1990; Van Rie
et al., 1990; London, 1992; Merritt and Hol, 1995) initiates a multistep process that results in
cell death. Consistent with this model, several RTX cytolysins kill cells by attaching to
leukocyte function-associated antigen-1 (LFA-1), a heterodimeric adhesion receptor formed
by the non-covalent association of α (αL; CD11a) and β (β2; CD18) subunits (Lally et al.,
1997; Wang et al., 1998; Ambagala et al., 1999; Li et al., 1999). LFA-1 is uniquely
expressed on the cell surfaces of innate and adaptive immune cells which explains, in part,
the restricted cytotoxicity exhibited by the toxin for cells from man, the Great Apes, and Old
World monkeys (Taichman et al., 1987).
Attachment of microorganisms to integrin heterodimers and entry into the cell through an
endocytic vacuole is a virulence strategy used by various intracellular bacteria (Relman et
al., 1990) and viruses (Wickham et al., 1993) to achieve entry into host cells. Receptormediated endocytosis of microbial pathogens is observed with a number of the 24 αβ
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integrin heterodimers but does not appear to be a function associated with LFA-1. LFA-1
plays multiple roles in the immune response such as mediating the migration of T cells
across endothelial cells, emigration from blood vessels (Warnock et al., 1998), crawling in
tissue (Dustin et al., 1997), and formation of the immunological synapse (Dustin et al.,
1998). A complex signalling system that is bidirectional and reciprocal (Dustin et al., 2004)
is necessary to accomplish the immunological multitasking required of this integrin. The
‘outside-in’ signal initiated by intercellular adhesion molecule-1 (ICAM-1) binding to
LFA-1 leads to integrin clustering and increased avidity for ligand, while its complementary
‘inside-out’ signal originates in the cytoplasm and results in conformational changes in
LFA-1 and an increased affinity for ICAM-1 (Dustin and Springer, 1989). Regions of the
target cell membrane that contain a non-random and asymmetrical distribution of cholesterol
and sphingolipids (lipid rafts) appear to play a role in the activation process in that,
following stimulation, LFA-1 accumulates in the lipid raft compartment (Leitinger and
Hogg, 2002).
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Here we test the hypothesis that the interaction between Ltx and LFA-1 results in target cell
responses that mimic ‘outside-in’ integrin activation signals. We demonstrate that Ltx
induces an elevation of [Ca2+]c and activation of calpain, an intracellular Ca2+-dependent
cysteine protease, which cleaves talin, a protein that anchors LFA-1 to the cytoskeleton,
allowing clustering of LFA-1 on the cell surface and lateral movement of the LFA-1/Ltx
complex to the raft compartment. We show that Ltx is able to mobilize [Ca2+]c in a mutant
cell line that does not express LFA-1 but is immune to the lethal effects of the toxin,
indicating that the initial phase of Ltx intoxication does not require an interaction of the
toxin with LFA-1, but that LFA-1 is required for movement of the toxin to the lipid microdomain. We demonstrate that intact lipid rafts are essential to Ltx cytotoxicity because
dispersion of rafts with methyl-β-cyclodextrin (MβCD) abolishes the ability of Ltx to kill
target cells and cytotoxicity is restored when the raft is reconstituted. Our findings directly
demonstrate that the interaction of an RTX toxin with LFA-1 is not a simple toxin docking
but contains many features of ‘outside-in’ integrin activation.

Results
Actinobacillus actinomycetemcomitans Ltx induces LFA-1 clustering in Jurkat (Jn.9) cells

NIH-PA Author Manuscript

To determine if the membrane distribution of LFA-1 is altered in Ltx-treated cells, toxintreated cells were compared with untreated cells and cells treated with heat-inactivated
leukotoxin (ΔLtx, 70°C, 60 min). Following staining with anti-CD11a mAb, the cells were
examined by confocal microscopy (Fig. 1, Confocal Microscopy), and the fluorescence
intensity of the membrane analysed using a standardized method (Stewart et al., 1998). It
was determined that a threshold intensity of 175 < 255 represented a significant value while
intensity between 80 < 174 represented non-significant background staining. Images with
the highest LFA-1 fluorescence intensity (i.e. in the pixel intensity range 175 < 255) are
represented by red colour and white was used to represent those areas whose intensity was
not significant (80 < 174; Fig. 1, Fluorescence Intensity). Unstimulated cells and cells
treated with ΔLtx exhibited very little high intensity LFA-1 fluorescence (red) when
compared with Ltx-treated cells. Statistical analysis (Kruskal–Wallis One Way ANOVA on
Ranks) of these measurements confirmed that the increase in LFA-1 fluorescence intensity
observed in Ltx-treated cells was significantly higher than in untreated cells or cells treated
with ΔLtx (P < 0.05) (Table 1). The increases in LFA-1 fluorescence in the Ltx-treated cells
can be explained by upregulation of LFA-1 expression or by clustering of the integrin. To
differentiate between these two possibilities, we utilized FACS® analysis to measure the
total surface LFA-1 expression of 10 000 cells from each experimental group. The FACS®
data (Fig. 1, FACS® Analysis) demonstrated equal expression of LFA-1 across all
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experimental groups thereby indicating that Ltx was inducing clustering of LFA-1 on target
cells and not increasing expression of LFA-1 in the Ltx-treated group.
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Ltx induces α4β 1 integrin clustering in Jn.9 and Jβ2.7 cells
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We believe that the LFA-1 clustering we observe in toxin-treated cells is either the result of
a direct interaction of Ltx with LFA-1 or Ltx is exerting a broader, non-specific effect on
target cells. If Ltx is inducing generalized cell activation, then we would expect to observe
clustering of other integrins as well. We tested this hypothesis by examining the ability of
10–9 M Ltx to induce clustering of another integrin, α4β1, using wild-type Jn.9 and Jβ2.7
cells (Weber et al., 1997). Jβ2.7 cells do not express either component of the αβ
heterodimer (CD11a or CD18) on the cell surface. The LFA-1 fluorescence signal in Jn.9
cells served as a positive control (Fig. 2). A statistically significant increase in LFA-1 signal
was observed in Jn.9 cells treated with Ltx (0.0235 ± 0.0024; P < 0.001) over a
corresponding untreated control (0.0079 ± 0.0009). Examination of the α4β1 fluorescence
in Ltx-treated Jn.9 cells (0.0207 ± 0.0008), using the same experimental conditions, showed
that the clustered distribution pattern of this integrin was similar to that observed for LFA-1
in Ltx-treated Jn.9 cells (0.0235 ± 0.0024). The ability of Ltx to cluster α4β1 (0.0209 ±
0.0016) in LFA-1-deficient, as well as LFA-1-expressing cells, is an indication that the
integrin mobilization is not the result of a toxin/LFA-1 interaction. It is possible that the
[Ca2+]c increases that had been observed in intoxicated cells (Taichman et al., 1991) might
be responsible for these observations.
Ltx mobilizes [Ca2+]c in the absence of LFA-1
We explored the effect of [Ca2+]c increases in LFA-1 clustering utilizing wild-type Jn.9 cells
and two Jn.9 mutants (Weber et al., 1997): Jβ2.7, an LFA-1-deficient cell line, and Jβ2.7/
hCD11a, a cell line produced by transfecting Jβ2.7 cells with a human CD11a transgene
resulting in the expression of wild-type levels of LFA-1 on their cell surfaces (Fig. 3A). The
earliest observable effect of Ltx on all three cell lines was an elevation of [Ca2+]c (Fig. 3B)
which occurred within 60 s after addition of the toxin to cultures. [Ca2+]c increases were not
observed when each corresponding cell line was exposed to ΔLtx. The Ltx-mediated
elevation of [Ca2+]c levels was decreased upon preincubation of the cells with 100 μM 2aminoethoxy-diphenyl borate (2-APB), an efficient blocker of store operated Ca2+ entry,
while no increases were observed in cells treated with 100 μM 2-APB and ΔLtx (Fig. 3C).
The ability of the toxin to mobilize [Ca2+]c in both LFA-1-positive and -negative cells
indicates that this initial phase of Ltx intoxication does not require an interaction of the toxin
with integrin.
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We then examined the ability of Ltx to kill the three target cell lines (Fig. 3D) and found that
while all cell lines had exhibited similar Ltx-induced [Ca2+]c increases, only those cells
expressing LFA-1 (Jn.9 and Jβ2.7/hCD11a) were killed in a dose-dependent manner as the
Ltx concentration was increased from 10–9 M to 10–6 M. The results are consistent with a
previous demonstration of passive adsorption of Ltx onto both toxin-sensitive cells and
certain toxin-resistant cells (Simpson et al., 1988) and indicates that while the interaction of
Ltx with target cell membranes results in elevation of [Ca2+]c, the presence of the LFA-1
heterodimer appears to be critical for cell lysis.
Ltx-induced clustering of LFA-1 involves reorganization of the cytoskeleton
LFA-1 is dispersed throughout the non-raft compartment of the membrane as a result of its
linkage to components of the cytoskeleton which both constrain lateral movement of the
integrin and confine it to this partition. Therefore, the LFA-1 clustering we observed in the
previous section could be the result of either a breakdown of the cytoskeletal attachment or,
conversely, from the formation of new cytoskeletal connections. To determine which of
Cell Microbiol. Author manuscript; available in PMC 2012 July 25.
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these possibilities is occurring in Ltx-treated cells, we investigated the effect of
jasplakinolide, a compound that stabilizes pre-existing actin filaments and promotes actin
polymerization (Bubb et al., 2000), as well as the compound, cytochalasin D (cD), which
disrupts the actin filament organization (Cooper, 1987).
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We analysed the net LFA-1-fluorescence intensity from Jn.9 cells in each of our
experimental and control groups to determine whether jasplakinolide affected the LFA-1
distribution of cells treated with Ltx (Fig. 4A and B). As expected, the net LFA-1
fluorescence intensity of cells stained with LFA-1 antibody (0.00595 ± 0.00181) increased
over twofold following the addition of Ltx (0.0128 ± 0.00276) to cultures (P < 0.01). On the
other hand, a 30 min preincubation with 1 μM jasplakinolide inhibited the Ltx induced
clustering of LFA-1 (0.00620 ± 0.00136) to the level of cells pretreated with jasplakinolide
alone (0.0058 ± 0.0004) or untreated control cells (0.00595 ± 0.00181). The results suggest
that changes in the actin cytoskeleton occur in cells exposed to Ltx. The observation that the
jasplakinolide and jasplakinolide plus Ltx experimental groups had LFA-1 fluorescence
signals that were similar to untreated controls (Fig. 4B) is an indication that jasplakinolide is
acting by blocking LFA-1 clustering and is not initiating receptor degradation. cD (4 μM)
disrupts actin filament organization, freeing LFA-1 from cytoskeletal restraints resulting in
an elevated LFA-1 signal in both cD (0.0126 ± 0.0014) and cD plus Ltx- (0.0119 ± 0.0011)
treated cells that was similar to the level seen in cells exposed to Ltx (0.0128 ± 0.0012) (Fig.
4B).
The ability of jasplakinolide to prevent integrin clustering reinforces the notion that
cytoskeletal reorganization is an early consequence of the interaction of toxin and target cell.
LFA-1 mobilization is a critical component of integrin activation (Kucik et al., 1996).
Therefore, we examined the effect of pretreatment with either jasplakinolide or cD on Ltx
cytotoxicity (Fig. 4C). Jasplakinolide-treated cells, exposed to Ltx, were not killed by the
toxin as expected due to the ability of this compound to stabilize the cytoskeleton and
prevent actin depolymerization. Contrary to our prediction, cD-treated cells were not killed
by Ltx (Fig. 4C) despite integrin clustering indicating that integrin clustering by itself is not
sufficient for Ltx cytotoxicity.
Talin, a protein that links LFA-1 to the cytoskeleton, is cleaved by calpain in Ltx-treated
cells
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Increases in [Ca2+]c activate many cytoplasmic enzymes and mediators which have been
implicated in integrin signalling and function. Previous studies have shown that the
clustering of LFA-1 is initiated by Ca2+ mobilization which leads to activation of calpain, a
cysteine protease (Stewart et al., 1998). Activated calpain is capable of cleaving talin, a
cytoskeletal protein that binds to the LFA-1 β chain cytoplasmic domain and tethers LFA-1
to the cytoskeleton (Kucik et al., 1996). We examined the ability of Ltx-activated calpain to
cleave talin, which would result in releasing LFA-1 from its cytoskeletal tether. Talin (250
kDa; Fig. 5A, untreated) was cleaved after a 30 min incubation with 10–9 M Ltx at 37°C,
resulting in the appearance of a 47 kDa proteolytic fragment in lipid raft fractions isolated
from Ltx-treated cells (Fig. 5A, Ltx). In contrast, no proteolytic cleavage product of talin
was observed in the lipid raft fractions of Ltx-treated cells pretreated with 100 μM calpeptin
(Fig. 5A, Calpeptin), a calpain inhibitor, for 30 min at 37°C. These findings suggest that
addition of Ltx to target cells results in an increase in [Ca2+]c, which activates calpain and
cleaves talin, freeing LFA-1 to move laterally within the plasma membrane.
As a follow-up experiment, we analysed the LFA-1 distribution in Ltx-treated cells
pretreated with 100 μM calpeptin (Fig. 5B). When compared with Ltx-stimulated cells,
untreated cells and cells pretreated with calpeptin showed significantly lower levels of high
intensity fluorescence (Table 2, P < 0.001;). The results suggest that inhibition of the
Cell Microbiol. Author manuscript; available in PMC 2012 July 25.
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cysteine protease, calpain, by calpeptin, results in LFA-1 bound to the cytoskeleton by talin,
preventing its lateral movement within the membrane and decreased clustering. To
determine if the addition of calpeptin had an effect on Ltx-mediated cytotoxicity (Fig. 5C),
Jn.9 cells were subjected to 30 min pretreatments of 100, 33 10, 3.3 and 1 μM calpeptin
before Ltx addition. Calpeptin treatment resulted in a in a dose-dependent inhibition of Ltxmediated cytotoxicity.
Association of Ltx and LFA-1 with lipid microdomains
Sucrose density gradient centrifugation was used to deter mine the location of Ltx and
LFA-1 in Ltx-treated and untreated cells. Significantly higher levels of LFA-1 and Ltx were
detected in raft fractions in Jn.9 cells exposed to 10–9 M Ltx compared with untreated cells
(Fig. 6A and B). By confocal microscopy, LFA-1 is shown to colocalize with the raft marker
CD55 in Ltx-treated cells but not in untreated cells (Fig. 6C).
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Although it has been possible to demonstrate the binding of Ltx to LFA-1 in pull down
experiments (Lally et al., 1997), the question arises as to whether the Ltx/LFA-1 interaction
is the result of independent migration of each element to the raft compartment or if binding
occurs outside the raft and the complex becomes raft associated. To address this question,
we again used the LFA-1-deficient mutant Jβ2.7 and Jβ2.7/hCD11a in which LFA-1
expression had been restored by transfection. Lipid raft fractions of each cell line were
examined for the presence of Ltx using polyclonal anti-Ltx antibody (Lally et al., 1989a).
Significantly lower amounts (P < 0.05) of Ltx were detected in lipid raft fractions of Jβ2.7
lacking LFA-1 compared with Jβ2.7/hCD11a cells, indicating that the presence of cell
surface LFA-1 is required for Ltx to enter the raft compartment (Fig. 7).
Ltx does not disrupt the integrity of the lipid raft compartment of target cells
Having demonstrated the association of Ltx and LFA-1 with lipid rafts, we wanted to
determine if toxin damages the raft. Jurkat cells were treated with Ltx for 1 h at 37°C, lysed
by homogenization in Triton X-100 and separated by sucrose density gradient
centrifugation. In both toxin-treated and -untreated cells, CD55, a
glycosylphosphatidylinositol (GPI)-linked protein, was detected in raft fractions 2–7 (Fig.
8A), while the human transferrin receptor, CD71, was detected in non-raft fractions 8–10
(Fig. 8B). Using confocal microscopy, the raft marker CD55 colocalized with Ctx which
binds specifically to the raft enriched glycosphingolipid, GM1 ganglioside (Fig. 8C). In
contrast, the CD71 did not colocalize with cholera toxin. The ability to separate raft (CD55)
and non-raft (CD71) proteins in the presence or absence of Ltx suggests that the toxin does
not destroy the integrity of lipid rafts in Ltx-treated cells.

NIH-PA Author Manuscript

Cholesterol depletion blocks Ltx-mediated cytotoxicity
To determine if lipid raft integrity is necessary for Ltx to kill cells, we examined the effect
of MβCD, an agent known to disrupt lipid rafts by removing cholesterol from the Jurkat cell
membrane (Kilsdonk et al., 1995). Jn.9 cells were subjected to three different MβCD
treatments and their rafts were visualized by confocal microscopy (Fig. 9A). Untreated cells
showed the typical patched appearance of rafts on the cell surface. In contrast, 10 mM
MβCD treatment disrupted the integrity of the lipid rafts, resulting in greatly diminished
GM1 ganglioside fluorescence. The specificity of cholesterol depletion on Ltx cytotoxicity
is observed in cells treated with 5 mM MβCD plus 5 mM MβCD-cholesterol conjugates.
Exposing the cells to the same concentration of MβCD as when cholesterol was depleted,
while providing cholesterol in the form of MβCD-cholesterol conjugates, facilitates the
incorporation of exogenous cholesterol into membranes resulting in restoration of membrane
rafts to a level similar to untreated cells. In a final group, Jurkat T cells were treated first
with 10 mM MβCD, washed and subjected to a second incubation with MβCD-cholesterol
Cell Microbiol. Author manuscript; available in PMC 2012 July 25.
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conjugate (at 0.5 mM cholesterol). This treatment restored Ctx fluorescence to wild-type
levels demonstrating that MβCD treatment does not damage cells and cholesterol depletion
is reversible. Analysis of cellular cholesterol of the four cell groups showed that treatment of
cells with 10 mM MβCD decreased cholesterol content approximately 50% from 1.86 ± 0.1
μM cholesterol/106 cells to 0.95 ± 0.08 μM cholesterol/106 cells when compared with
untreated Jn.9 cells (Table 3) while treatment of cells with 5 mM MβCD decreased
cholesterol content by approximately 30% compared with untreated cells. Cells treated with
5 mM MβCD plus 5 mM MβCD-cholesterol complex or cells treated with 10 mM MβCD to
deplete cholesterol followed by repletion with MβCD-cholesterol complexes had levels
which exceeded those of untreated cells.
Ltx treatment of these cell groups followed by a trypan blue exclusion assay (Fig. 9B)
showed a marked decrease in the percentage cytotoxicity in Ltx-stimulated cells pretreated
with 10 mM MβCD (12.4 ± 2.5%) compared with untreated cells (45.9 ± 2.1%) (P < 0.01)
which was reversed with 5 mM MβCD plus 5 mM MβCD-cholesterol mix (52.8 ± 8.3%)
and repletion of cholesterol with MβCD-cholesterol inclusion complexes at 0.5 mM
cholesterol (53.1 ± 3.75%). The results suggest that cholesterol depletion by MβCD disrupts
the cellular processes that are involved in Ltx-mediated cytotoxicity.

Discussion
NIH-PA Author Manuscript

Expression of LFA-1 on the target cell surface is necessary for several RTX cytolysins to
kill cells (Lally et al., 1997; Wang et al., 1998; Ambagala et al., 1999; Li et al., 1999). In the
current study, we used Ltx as a model to identify and characterize the early steps in RTX
intoxication in a Jurkat T cell line. The addition of Ltx to cells results in an aggregation of
LFA-1 on the target cell surface (Fig. 1). The ability of Ltx to elevate [Ca2+]c levels
(Taichman et al., 1991) and heat inactivation to ablate these changes suggests that the
clustering of both LFA-1 and another integrin, α4β1 (Fig. 2), are part of the initial effect
that the toxin has on the cell. Furthermore, Ltx induced increases in [Ca2+]c (Fig. 3B) as
well as clustering of α4β1 in Jβ2.7, an LFA-1-deficient Jurkat mutant, indicates that the
integrin mobilization observed in our studies is the result of increased [Ca2+]c levels and is
not dependent upon an interaction of Ltx and LFA-1.
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Elevations of [Ca2+]c are not uncommon responses to bacterial protein toxins and have been
reported in cells exposed to both multivalent and pore-forming toxins (Fivaz et al., 1999;
Tran Van Nhieu et al., 2004). For example, Aeromonas aerolysin and Listeria listeriolysin,
are secreted as monomers and assemble on the cell surface forming a transmembrane pore
through which Ca2+ passes into the cytosol. However, the ability of Ltx to increase [Ca2+]c
levels in both toxin-sensitive and toxin-resistant cells (Fig. 3B) is provocative, suggesting
that rather than forming a transmembrane pore, Ltx is initiating release of Ca2+ from internal
stores. The ability of 2-APB (Bootman et al., 2002), a reliable blocker of store-operated
Ca2+ pathways, to inhibit these increases (Fig. 3C) reinforces this premise and is consistent
with observations made with other RTX toxins (Uhlen et al., 2000; Cudd et al., 2003). The
fact that Ltx stimulates [Ca2+]c elevations of equal magnitudes in both toxin-sensitive cells,
such as wild-type Jn.9 and LFA-1-reconstituted Jβ2.7/hCD11a cells, and the toxin-resistant
Jβ2.7 cells (Fig. 3B), suggests that a simple elevation of [Ca2+]c, is probably not responsible
for cell death but is a prelude for additional downstream events that are required for
cytolysis.
In inactive immune cells, LFA-1 molecules are dispersed throughout the membrane and
their lateral mobility is restricted by attachment to the cytoskeleton. Integrin clustering
therefore implies that cytoskeletal reorganization is occurring in Ltx-treated cells.
Stabilization of existing actin filaments and stimulating de novo actin polymerization by
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pretreatment of target cells with jasplakinolide inhibited both clustering and cell death (Fig.
4), indicating that mobilization of LFA-1 is necessary for cytolysis. On the other hand, cD,
disassembles the actin cytoskeleton resulting in increased LFA-1 clustering in both untreated
controls and Ltx-treated cells. However, in spite of the clustering, cD-treated cells were also
impervious to the effects of the toxin suggesting that while both Ltx and cD treatment affect
the cytoskeleton, changes induced by Ltx are different than the disassembly that occurs with
cD. The reason for the resistance of cD-treated cells to Ltx is not immediately clear. cD acts
by capping the barbed ends of F-actin filaments thereby, preventing their lengthening
(Cooper, 1987). As concentrations of F actin have been identified within raft membrane
patches of Jurkat T cells (Harder and Simons, 1999), cytotoxicity may be dependent upon
both LFA-1 mobilization and the integrity of these cD-sensitive lipid raft/cytoskeleton
connections.
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Toxins that utilize lipid rafts as part of their virulence schemes have receptors that are raft
components (Harder and Simons, 1999; Brown and London, 2000). Interactions of Ltx and
lipid rafts differ from the paradigm of these toxins because integrins do not associate with
lipid micro-domains until after cell activation (Stewart et al., 1998; Leitinger and Hogg,
2002). Analysis of raft fractions from Ltx-treated LFA-1-expressing (Jn.9, Jβ2.7/hCD11a)
and LFA-1-deficient mutant cells (Jβ2.7) show that only cells expressing LFA-1
accumulated Ltx in the raft, indicating that an interaction with LFA-1 is required for
targeting Ltx to the raft (Fig. 7). At present, it is not known whether Ltx is binding to LFA-1
that is already clustered in the raft or if Ltx binds LFA-1 outside the raft and the complex
becomes raft associated. The [Ca2+]c increases described above appear to have a role in the
movement of LFA-1 to the raft (Stewart et al., 1998) through the activation of calpain.
Through the use of calpeptin, a selective inhibitor of calpain, we identified talin, a 250 kDa
homodimeric cytoskeletal protein, to be a substrate for activated calpain in Ltx-treated
Jurkat cells. The major integrin-binding site lies within the talin head (Liu et al., 2000) and
calpain cleaves between the talin head (47 kDa) and rod (203 kDa) domain (Critchley,
2000). When compared with untreated or cells treated with calpeptin, the talin head domain
was detected in rafts of Ltx-treated cells (Fig. 5A), indicating that activated calpain cleaves
talin, physically releasing LFA-1 from cytoskeletal restraints and allowing movement of
LFA-1 and the talin head domain to lipid rafts. Calpain inhibition by calpeptin also inhibited
clustering and subsequent killing of toxin-treated cells (Fig. 5B and C). The fact that talin
bound to integrin β tails is able to colocalize with activated integrins (Tadokoro et al., 2003),
suggests that cleavage of talin plays a critical role in the integrin activation by Ltx.
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Toxin, integrin and lipid rafts sound an arpeggio that transition the Ltx reaction from an
initial integrin activation stage, characterized by [Ca2+]c increases and LFA-1 migration to
rafts, to the lytic stage that results in the death of LFA-1-bearing cells. The mechanism by
which this occurs remains to be elucidated. Aggregation of toxin and integrin in lipid rafts
(Figs 6 and 7) could result in membrane damage and subsequent cell death, however, also
possible, is that a signal through LFA-1 is upregulating the apoptotic machinery of the target
cell. Integrins possess a classical cell signalling capability in the presence of their cognate
ligand, however, some also produce a negative cell death promoting signal in its absence
(Frisch and Screaton, 2001; Stupack, 2005). The role that β2 integrins play at the crossroads
of immune function and cell death is only beginning to be understood.
Our studies provide an indication that Ltx-induced [Ca2+]c increases are capable of
influencing the mobilization of integrins. Calcium plays a pivotal role in immune cell
functions through the activation of transcription factors that induce several key genes that
modulate diverse genetic programs, including cell proliferation, cell differentiation, effector
function and cell death (Teague et al., 1999). Cellular Ca2+ signals generated during these
interactions are the sequelae of complex interactions between a variety of Ca2+ reservoirs
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that supply, and sinks that assimilate, this divalent cation. Our current analysis is but an
initial snapshot into what appears to be a dynamic process initiated by Ltx and target cells.
Additional studies designed at determining the source of the Ca2+ will provide valuable
insight into what is a complex environment.
In summary, the interaction of Ltx with toxin-susceptible cells mimics integrin activation
and results an enrichment of both toxin and LFA-1 in the lipid rafts of target cells.
Subsequent cytoskeletal reorganization within the intact raft is essential for Ltx-mediated
cytotoxicity.

Experimental procedures
Antibodies and reagents
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Anti-Ltx was described previously (Lally et al., 1989a,b). Anti-CD11a, clone G25.2; antiCD55, clone IA10; and anti-CD71, clone M-A712, were purchased from BD Biosciences,
Pharmingen (San Diego, CA); anti-α4β1, clone PS/2, from Chemicon International
(Temecula, CA); Alexa Fluor®-647 conjugated Ctx subunit B, streptavidin, Alexa
Fluor®-488 conjugated secondary antibodies from Invitrogen, Molecular Probes (Carlsbad,
CA); anti-cholera toxin B-subunit, calpeptin, jasplakinolide, cD from Calbiochem (San
Diego, CA); biotinylated anti-CD55 from R and D Systems (Minneapolis, MN); antitalin,
clone TA205, from Upstate (Charlottesville, VA); MβCD, fatty acid free BSA, 2-APB and
cholesterol from Sigma (St Louis, MI).
Cell lines
The LFA-1 expressing human T lymphoma Jurkat cell line, Jn.9, and the LFA-1-deletion
mutant, Jβ2.7 (Weber et al., 1997) were gifts from Dr Lloyd Klickstein, Harvard, MA.
Jβ2.7/ hCD11a was created by cloning the human CD11a gene (a gift from Martyn
Robinson, Celltech, Slough, UK) into the mammalian expression vector pCDNA6/
V5®(Invitrogen), and transfecting into Jβ2.7. All cells were maintained at 37°C under 5%
CO2 in RPMI 1640 (Mediatech Cellgro, Herndon, VA) containing 10% FCS, 0.1 mM MEM
non-essential amino acids, 1× MEM vitamin solution, 2 mM L-glutamine and 50 μg ml–1
gentamicin. Transfected cells were screened and maintained in 5 μg ml–1 blasticidin.
Immunofluorescence labelling and raft patching
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Cells (3 × 106) were incubated with 10 μg ml–1 anti-CD11a (clone G25.2) or anti-α4β1
(clone PS/2) antibody, with or without 10–9 M Ltx or heat-inactivated (70°C, 1 h) Ltx at
37°C for 30 min followed by detection with 5 μg ml–1 Alexa Fluor®-488 conjugated
secondary antibodies. 1 μM jasplakinolide, 4 μM cD and 100 μM calpeptin were added to
cells for 30 min at 37°C before Ltx treatment. Cells were mounted by centrifugation at 1015
g for 5 min onto Cell-Tak™-coated (BD Biosciences, San Diego, CA) 0.17 mm Delta T
dishes (Fisher Scientific, Hampton, NH). Lipid raft aggregation or patching with 100 μg
ml–1 Alexa Fluor®-647 conjugated cholera toxin subunit B and 0.5 mg ml–1 anti-cholera
toxin subunit B IgG (1:150 dilution) in untreated or cholesterol depleted and repleted cells,
and colocalization of lipid rafts with anti-CD55 and anti-CD71 were performed according to
Leitinger and Hogg (Leitinger and Hogg, 2002).
Confocal microscopy and immunofluorescence quantification
Images were acquired with a Nikon Eclipse TE300 microscope (100× objective), connected
to a Bio-Rad Radiance Confocal Scanning System and analysed using the Laser Sharp 2000
Software (Bio-Rad Laboratories, Hercules, CA). Optical images of cell sections (512 × 512
pixels) were digitally recorded. LFA-1 fluorescence in the pixel intensity range (175 < 255)
(Meta-Morph® version 6.0, Molecular Devices, Sunnyvale, CA) was depicted in red while
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fluorescence intensities in the pixel range (80 < 174) was depicted in white. Statistical
analysis of LFA-1 fluorescence intensities was performed using SigmaStat® 3.1 (Systat®
Software, Port Richmond, CA).
FACS®analysis
LFA-1 expression was determined by FACS® analysis utilizing TS1/22 or TS1/18 (ATCC,
Rockville, MD) as described previously (Lally et al., 1997).
Isolation and analysis of membrane rafts
Triton X-100-resistant membrane rafts were prepared from Ltx and calpeptin-treated cells as
previously described (Seno et al., 2001). Equal amounts of protein from each fraction were
analysed by SDS-PAGE/Western and dot blotting, scanned with the Kodak Digital Science
Image Station® using the program Kodak ID3.5, or with the Personal Densitometer SI using
the Molecular Dynamics Software Version NT4 (Amersham Biosciences, Piscataway, NJ).
The net fluorescence intensity from three separate experiments was plotted against fraction
number. Lipid rafts of calpeptin-treated cells were precipitated in ice-cold MOPS buffer,
centrifuged at 244 980 g for 45 min at 4°C and resuspended in MOPS buffer before
subjecting to SDS-PAGE/Western blotting and detection with antitalin antibody.
Ltx-mediated cytotoxicity

NIH-PA Author Manuscript

The trypan blue cytotoxicity assay was described previously (Brogan et al., 1994). To test
for inhibition, the cells were pre-treated with 100, 33, 10, 3.3 and 1 μM calpeptin, 1 μM
jasplakinolide or 4 μM cD for 30 min before addition of 10–9 M Ltx.
MβCD treatments
Cholesterol depletion and replenishment was performed as described (Leitinger and Hogg,
2002). Cholesterol concentration in lipid raft fractions of untreated and ΜβCD-treated cells
was performed using the Amplex Red Cholesterol Assay Kit (Invitrogen), as described by
the manufacturer's instructions.
Measurement of [Ca2+]clevels
[Ca2+]c levels were performed on indo-1-loaded target cells using a Hitachi F2500
Fluorescence Spectrophotometer with an excitation wavelength of 338 nm and emission
wavelengths of 405 and 480 nm (Ali et al., 2000).
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Fig. 1.

Clustering of LFA-1 in Ltx-treated cells. Jn.9 cells were incubated with 10–9 M Ltx or ΔLtx
and 10 μg ml–1 anti-CD11a at 37°C for 30 min. The cells were fixed and stained with Alexa
Fluor®-488 conjugated secondary antibody before visualizing by confocal microscopy
under a 100× objective (left panel). When compared with untreated cells, cells treated with
ΔLtx and cells stained only with secondary antibodies, Ltx-treated cells appeared to have
focal increases in fluorescence intensity in the cell membrane. Fluorescence intensities for
each sample were quantified using the Metamorph® 6.0 program and images in the pixel
intensity range (< 174) are depicted in white while the pixel intensity range (175 < 255) are
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in red (middle panel). An FACS® analysis was performed to measure total surface
expression of LFA-1 of 10 000 cells from each group (right panel). Bar, 10 μm.
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Fig. 2. Clustering of α4β1 integrin in Ltx-treated Jn.9 and Jβ2.7 cells

A. Cells were incubated as in Fig. 1 with 10 μg ml–1 anti-LFA-1 or anti-α4β1. When
compared with untreated cells (top panel), LFA-1 and the α4β1 integrin appeared to be
clustered on the cell membrane of both Jn.9 and Jβ2.7 Ltx-treated cells (bottom panel). Bar,
10 μm. B. The levels of fluorescence for each sample were quantified using the
Metamorph® 6.0 Program. Statistical analysis was performed on 60 cells of each group.
Values reported as mean ± SEM of at least seven determinations from a representative
experiment. *P < 0.001 versus LFA-1-stained Jn.9 cells; **P < 0.001 versus α4β1-stained
Jn.9 cells; ***P < 0.001 versus α4β1-stained Jβ2.7 cells.
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Fig. 3. Mobilization of [Ca2+]c in Ltx-treated T cells
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A. FACS® analysis of 10 000 cells in each group show that the CD11a transfected mutant
Jβ2.7/hCD11a and the wild-type Jn.9 cells express both components of the LFA-1
heterodimer (CD11a and CD18) in contrast to the mutant, LFA-1-deficient Jβ2.7 cells.
B. An elevation of [Ca2+]c was observed within 60 s after stimulation of Jn.9 (▲,△), Jβ2.7
(●○) and Jβ2.7/hCD11a (■, □ ) cells with 10–9 M Ltx (filled symbols) in contrast to cells
treated with ΔLtx (open symbols).
C. Preincubation of Jn.9 cells with 100 μM 2-APB decreased Ltx-induced [Ca2+]c increases
while incubation with 2-APB with ΔLtx had no effect on [Ca2+]c levels.
D. When Jn.9 (▲), Jβ2.7/hCD11a (■) and Jβ2.7 (●) cells were subjected to increasing
(10–9 M to 10–6 M) concentrations of Ltx, cells expressing LFA-1 were killed in a dosedependent manner compared with cells lacking LFA-1, suggesting that the initial elevation
of [Ca2+]c and Ltx-mediated cytotoxicity occur independently of each other.
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Fig. 4. Ltx induces reorganization of the actin cytoskeleton

A. Cells were treated with 1 μM jasplakinolide (Jas) or 4 μM cD prior to treatment with
10–9 M Ltx, and incubated with anti-CD11a mAb as described in Fig. 1. In the presence or
absence of Ltx, jasplakinolide prevented LFA-1 clustering (middle panel). In contrast, cD
promoted clustering of Ltx-treated and untreated cells (right panel). In the absence of
jasplakinolide or cD, Ltx induced clustering of LFA-1 (left panel). Bar, 10 μm.
B. The level of LFA-1 fluorescence was determined as in Fig. 2. Ltx-treated cells (■); no
Ltx (□). The LFA-1 fluorescence intensity in Ltx-treated cells is significantly higher than
that of the untreated control and groups pretreated with jasplakinolide but showed similarly
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high LFA-1 fluorescence intensities as compared with groups pretreated with cD. Values
represent mean ± SEM of at least seven determinations from a representative experiment.
*P < 0.001 versus untreated and jasplakinolide-treated cells. N.S., not significant compared
to untreated control cells. C. Cell viability was determined using the trypan blue assay
(Brogan et al., 1994). Ltx-treated cells (■); ΔLtx-treated cells (□). Ltx-treated cells showed
significantly greater cytotoxicity than its corresponding untreated control, while groups
pretreated with either jasplakinolide or cD were not killed by Ltx. Values represent the mean
± SEM of three determinations from a representative experiment. *P < 0.001 versus cells
receiving neither Ltx nor jasplakinolide or cD pretreatments.
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Fig. 5. Effect of calpain inhibition on Ltx-treated cells
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A. The 47 kDa talin head proteolytic fragment resulting from cleavage of the 250 kDa intact
talin protein was detected in a Western blot of the detergent-resistant membrane fraction of
Ltx-treated cells with an antitalin monoclonal antibody (clone TA205). No talin cleavage
was observed in untreated cells or Ltx-treated cells pretreated with calpeptin.
B. Cells were pretreated with 100 μM calpeptin (30 min, 37°C) before incubating with 10
μg ml–1 anti-CD11a and Ltx as in Fig. 1. In contrast to Ltx-stimulated cells, untreated cells
and cells pretreated with calpeptin showed significantly lower levels of high intensity
fluorescence (panel B and Table 2). Bar, 10 μm.
C. Cells were pretreated with 100, 33, 10, 3.3 or 1 μM calpeptin, before Ltx addition. Cells
treated with Ltx and ΔLtx served as controls. Viability was determined using trypan blue
exclusion assay and values represent the mean ± SEM of three determinations from a
representative experiment. *P < 0.001 versus Ltx-treated cells; NS, not significant versus
Ltx-treated cells.

Cell Microbiol. Author manuscript; available in PMC 2012 July 25.

Fong et al.

Page 19

NIH-PA Author Manuscript
NIH-PA Author Manuscript

Fig. 6. Ltx and LFA-1 migrate to lipid rafts in Ltx-treated cells
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A and B. Lipid raft fractions from sucrose density gradients were analysed using antibodies
to LFA-1 (A) and Ltx (B). Western blots were scanned and the average pixel intensity was
plotted against fraction number. Values represent mean ± SEM of three independent
experiments. Significantly higher amounts of LFA-1 and Ltx were detected in raft fractions
in Jn.9 cells exposed to 10–9 M Ltx (●) compared with untreated cells (○). *P < 0.05 and
(N.S., not significant) versus untreated cells of each corresponding fraction.
C. Colocalization of LFA-1 (green) with the lipid raft marker CD55 (red) in Ltx-treated Jn.9
cells, in contrast to untreated cells. LFA-1 was detected as in Fig. 1. CD55 was detected
using 20 μg ml–1 biotin labelled polyclonal goat anti-CD55 and Alexa Fluor®-647
conjugated streptavidin. Bar, 1 μm.
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Fig. 7.

Cells expressing LFA-1 mobilize Ltx to lipid rafts. Ltx was detected in raft fractions of
Jβ2.7/hCD11a (LFA-1 expressing) cells exposed to Ltx (●) but not in Ltx-treated mutant
Jβ2.7 cells lacking LFA-1 (○). Ltx on the Western blots of lipid raft fractions were scanned
as in Fig. 6. *P < 0.05 and (N.S., not significant) versus Ltx-treated Jβ2.7 cells of each
corresponding fraction.
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Fig. 8.

Analysis of lipid raft fractions. Fractions collected from the top of the gradient were run on
SDS-PAGE and subjected to Western blot and probed with CD55 and CD71 antibodies. A
and B. CD55 was detected in lipid raft fractions 2–7 (A), while CD71 was detected in nonraft fractions 8–10 (B), in the presence (●) or absence (○) of Ltx. The average pixel
intensity of three independent experiments was obtained by scanning dot blots of lipid raft
fractions with the Personal Densitometer SI using the Molecular Dynamics, version NT4,
software. Error bars denote SEM (P < 0.05).
C. Confocal images of Jn.9 cells showing colocalization of cholera toxin (Ctx) with CD55 in
lipid rafts and no colocalization with CD71. Bar, 1 μm.
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Fig. 9. MβCD treatment of Ltx-stimulated cells abolishes Ltx-mediated cytotoxicity

A. Jn.9 cells were subjected to various MβCD treatments before staining for lipid rafts as
described in Experimental procedures. Bar, 1 μm.
B. Cells were subjected to the various MβCD treatments before incubating with 10–9 M Ltx
(■) or ΔLtx (□). Surviving cells were counted and expressed as a percent of an untreated
control. Values represent the mean ± SEM of three determinations from a representative
experiment. *P < 0.05 versus cells treated only with Ltx; N.S., not significant versus cells
treated only with Ltx.
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Table 1

Net LFA-1 fluorescence intensity of Ltx-treated Jurkat cells.
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Treatment

Average fluorescence intensity/cell

10–9 M Ltx

0.0145 ± 0.0028

Heat-inactivated 10–9 M Ltx

0.0044 ± 0.0004

Untreated
Secondary antibody only

*
*

0.0057 ± 0.0009
0.0002 ± 0.0001

Cells were incubated with anti-CD11a and 10–9 M Ltx at 37°C for 30 min, fixed and stained with Alexa Fluor®-488 conjugated secondary
antibody. Fluorescence intensity for each sample was quantified using Metamorph® 6.0. Statistical analysis of these measurements is reported as
mean ± SEM of 60 cells.

*

P < 0.05 versus Ltx-treated cells.
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Table 2

Calpeptin decreases Ltx induced LFA-1 clustering.
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Treatment

Average fluorescence intensity/cell

10–9 M Ltx

0.0183 ± 0.0027

100 μM calpeptin + 10–9 M Ltx

0.00905 ± 0.0012

50 μM calpeptin + 10–9 M Ltx

0.0105 ± 0.0013

25 μM calpeptin + 10–9 M Ltx

0.0109 ± 0.0018

*
*
*
*

Untreated

0.00907 ± 0.0008

Secondary antibody only

0.0001 ± 0.00

Cells were pretreated with 100, 50 and 25 μM calpeptin for 30 min at 37°C. 10–9 M Ltx was added to cells and stained for LFA-1 as described in
Experimental procedures. Fluorescence intensity for each sample was quantified using Metamorph® 6.0. Statistical analysis of these measurements
is reported as mean ± SEM of 60 cells.

*

P < 0.001 versus Ltx-treated positive control.
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Table 3

Lipid raft cholesterol levels in normal and MβCD-treated Jn.9 cells.
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Treatment

μM cholesterol/106 cells

None

1.86 ± 0.10

*

5 mM MβCD

1.23 ± 0.21

*

10 mM MβCD

0.95 ± 0.08

5 mM MβCD + 5 mM MβCD-cholesterol

5.17 ± 0.34

10 mM MβCD + 0.5 mM repleted cholesterol

6.82 ± 0.20

Jn.9 cells were subjected to one of four MβCD treatments at 37°C for 30 min. Untreated cells served as a control. The cholesterol content of lipid
rafts from MβCD-treated and untreated cells was determined using a Amplex Red Cholesterol Assay Kit (Molecular Probes, Invitrogen). Values
represent mean ± SEM of three separate experiments.

*

P < 0.01 versus untreated Jn.9 cells.
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